---
category: news
title: "Using AI to analyze large amounts of biological data"
excerpt: "Researchers at the University of Missouri are applying a form of artificial intelligence (AI) — previously used to analyze how National Basketball Association (NBA) players move their bodies — to now help scientists develop new drug therapies for medical treatments targeting cancers and other diseases."
publishedDateTime: 2022-05-05T16:54:00Z
originalUrl: "https://www.eurekalert.org/news-releases/951857"
webUrl: "https://www.eurekalert.org/news-releases/951857"
type: article
quality: 41
heat: -1
published: false

provider:
  name: EurekAlert!
  domain: eurekalert.org

topics:
  - AI in Healthcare
  - AI
  - Machine Learning

images:
  - url: "https://earimediaprodweb.azurewebsites.net/Api/v1/Multimedia/aa95ceeb-d67b-4a0b-92e6-70483ee2ce4c/Rendition/low-res/Content/Public"
    width: 500
    height: 700
    isCached: true

related:
  - title: "Using AI to analyze large amounts of biological data"
    excerpt: "Researchers are applying a form of artificial intelligence (AI) -- previously used to analyze how National Basketball Association (NBA) players move their bodies -- to now help scientists develop new drug therapies for medical treatments targeting cancers and other diseases."
    publishedDateTime: 2022-05-05T21:23:00Z
    webUrl: "https://www.sciencedaily.com/releases/2022/05/220505143820.htm"
    type: article
    provider:
      name: Science Daily
      domain: sciencedaily.com
    quality: 49
  - title: "One to Watch Companies - AI, Analgesia, Immunologicals"
    excerpt: "One company, Labstep, aims to help scientists achieve this. Japanese AI specialist Elix is to commence work on a joint research project with Shionogi, leveraging its Elix Synthesize platform. PhoreMost, a UK-based biopharma dedicated to developing drugs ..."
    publishedDateTime: 2022-05-02T09:57:00Z
    webUrl: "https://www.thepharmaletter.com/listing/one-to-watch-companies/ai-analgesia-immunologicals?tagid[]=95224&tagid[]=8130&tagid[]=41"
    type: article
    provider:
      name: The Pharma Letter
      domain: thepharmaletter.com
    quality: 17

secured: "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;+jHsvmhtDxTH+QIgR6dPww=="
---

